Daniel LeSueur, Chief Operating Officer at Health Catalyst, Inc. (HCAT), sold 33,804 shares at $4.52 ($153K) on 2025-03-05, disclosed to the SEC on 2025-03-10.
Scheduled sale ($153k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.52 | 16,902 | $76K | 50.0% |
| 2 | $4.52 | 16,902 | $76K | 50.0% |
| Total | $4.52 avg | 33,804 | $153K | 100% |
| Filing → |
| HCAT | SELL | 2025-02-06 | $30K | — | Filing → |
| HCAT | SELL | 2025-01-10 | $39K | — | Filing → |
| HCAT | SELL | 2024-12-06 | $351K | — | Filing → |